Differential clinical manifestations and clinical outcome of cancer-related pulmonary embolism.
Conclusions: Although PE in cancer patients were seem to be less aggressive initially, compared to those without cancer, they had significantly poor prognosis. Given a high rate of recurrent VTE and relatively similar risk of anticoagulation associated bleeding events in cancer patients, more active treatment of PE is warranted in cancer patients.
PMID: 31394894 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Kim MS, Chang H, Lee SY, Shin SH, Park H, Chang SA, Park TK, Kim DK, Kim EK Tags: Korean J Intern Med Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Internal Medicine | Pulmonary Thromboembolism | Thrombosis